HIMS vs LFMD
HIMS: A consumer-first digital health platform transforming the fulfillment of healthcare services and wellness products through an integrated telehealth and pharmacy model. LFMD: LifeMD is a vertically integrated, subscription-based telehealth platform that combines virtual medical care with internal pharmacy fulfillment to provide accessible, longitudinal patient care.
Side-by-side fundamentals
| Metric | HIMS | LFMD | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $28.06 | $2.65 | |
| Market cap | $6.5B | $128M | |
| P/E as of 2026-10-08 | n/a | 311.76 | |
| Net margin FY2025, SEC XBRL | +5.5% | +7.4% | LFMD higher |
| Gross margin FY2025, SEC XBRL | +73.8% | +85.7% | LFMD higher |
| Operating margin FY2025, SEC XBRL | +4.5% | -4.0% | HIMS higher |
| ROE FY2025, SEC XBRL | +23.7% | +62.0% | LFMD higher |
| ROA FY2025, SEC XBRL | +6.0% | +20.4% | LFMD higher |
| Debt / equity as of 2026-09-03 | 2.18 | 0.00 | LFMD lower |
| Revenue growth (YoY) as of 2026-09-03 | +32.8% | -16.7% | HIMS higher |
| Revenue CAGR (3y) SEC XBRL | +64.5% | +17.7% | HIMS higher |
| Dividend yield as of 2026-09-03 | n/a | +1.9% | |
| Dividend streak (yrs) SEC XBRL | 0 | n/a | |
| Beta as of 2026-09-03 | 2.36 | 1.64 | |
| 1-year return as of 2026-10-08 close | -51.8% | -60.1% | HIMS higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.